NIR Light Degradable Antimony Nanoparticle Based Drug Delivery Nanosystem for Synergistic Chemo-Photothermal Therapy In Vitro.

Solomon Tiruneh Dibaba,Riccarda Caputo,Wensong Xi,Jin Zhong Zhang,Ruoyan Wei,Qiang Zhang,Jianhua Zhang,Wei Ren,Lining Sun
DOI: https://doi.org/10.1021/acsami.9b20249
IF: 9.5
2019-01-01
ACS Applied Materials & Interfaces
Abstract:A novel drug delivery nanosystem based on near-infrared (NIR) light degradable antimony nanoparticles (AMNP) has been developed for synergistic chemo-phototherapy in vitro. The mono-dispersed AMNP were synthesized by using a simple and cost effective method. Positively charged doxorubicin hydrochloride (DOX) was loaded onto the negatively charged surface of AMNP via electrostatic interaction and finally modified by polyacrylic acid (PAA) to enhance biocompatibility. Under NIR (808 nm) laser irradiation of the AMNP-DOX-PAA nanosystem, not only high photothermal conversion efficiency of AMNP was achieved but also a pH dependent DOX release was enhanced due to laser induced hyperthermia. As a consequence, almost all the HeLa cells (around 97%) were killed because of the combined effects of chemotherapy and photothermal therapy. More interestingly, AMNP showed very fast (about 10 min) laser induced degradation that may help to minimize long term toxicity after therapy by using same wavelength NIR laser irradiation (808 nm). Computational total energy calculations and molecular dynamics simulations based on density functional theory (DFT) suggest that the NIR laser irradiation induces a photothermally activated reaction on the surface of AMNP in water, which can lead to surface degradation via formation of Sb-H bonds first and then Sb-OH bonds upon further increase of temperature. This work demonstrates a simple platform that has potential applications for synergistic and highly effective chemo-photothermal therapy based on photodegradable nanoparticles.
What problem does this paper attempt to address?